Stocks and Investing Stocks and Investing
Tue, August 16, 2022
[ 12:00 AM ] - WOPRAI
Haendel St. Juste Maintained (BRX) at Strong Buy with Increased Target to $26 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Wei Xiong Upgraded (BZ) to Strong Buy and Decreased Target to $28 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Charles Ryhee Maintained (CAH) at Hold with Increased Target to $72 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Raimo Lenschow Maintained (BASE) at Buy with Increased Target to $23 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Aaron Kessler Maintained (ZIP) at Strong Buy with Decreased Target to $30 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Trevor Young Maintained (ZIP) at Buy with Decreased Target to $25 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Tyler Radke Downgraded (ZM) to Strong Sell and Held Target at $91 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Puneet Souda Maintained (A) at Buy and Held Target at $145 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Carter Gould Maintained (APLT) at Hold with Decreased Target to $2.25 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Keith Weiss Maintained (WDAY) at Buy with Decreased Target to $282 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Conor Siversky Maintained (WELL) at Strong Buy with Decreased Target to $93 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Marc Solecitto Maintained (WMB) at Buy with Increased Target to $39 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Kevin Dede Maintained (WISA) at Strong Buy on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Peter Benedict Maintained (WMT) at Buy with Increased Target to $52 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Christopher Horvers Maintained (WMT) at Hold and Held Target at $43 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Edward Kelly Maintained (WMT) at Buy with Increased Target to $52 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
David Amsellem Initiated (ALKS) at Hold and Held Target at $26 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Peter Skibitski Downgraded (AIN) to Hold on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Scott Fortune Downgraded (AGFY) to Hold and Held Target at $300 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Salim Syed Maintained (ATRA) at Strong Buy with Decreased Target to $775 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Julian Harrison Downgraded (AVTE) to Hold on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Chandni Luthra Maintained (AVB) at Strong Buy with Increased Target to $248 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Stan Zlotsky Maintained (VEEV) at Hold with Increased Target to $190 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Tien-Tsin Huang Maintained (V) at Buy with Increased Target to $272 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Anthony Vendetti Maintained (UGRO) at Strong Buy with Decreased Target to $12 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Eric Beder Maintained (UGRO) at Strong Buy with Decreased Target to $8 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Chandni Luthra Maintained (UDR) at Strong Buy with Increased Target to $57 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Salim Syed Maintained (UBX) at Strong Buy with Increased Target to $80 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Tien-Tsin Huang Downgraded (TNET) to Sell and Held Target at $96 on, Aug 16th, 2022
[ 12:00 AM ] - WOPRAI
Chris Shibutani Maintained (TRDA) at Hold with Increased Target to $13 on, Aug 16th, 2022

Chris Shibutani Maintained (TRDA) at Hold with Increased Target to $13 on, Aug 16th, 2022


Published on 2024-10-27 22:41:02 - WOPRAI, Chris Shibutani
  Print publication without navigation


Chris Shibutani of Goldman Sachs, Maintained "Entrada Therapeutics, Inc." (TRDA) at Hold with Increased Target from $10 to $13 on, Aug 16th, 2022.

Chris, nor any peers, have made any analyst calls on TRDA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources